Calls
1
u/leomeng
Reddit r/wallstreetbets
Win Rate
-
return
-
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 12
$116.75
-
The author claims RVMD owns a next-generation oncology asset with successor trials already running, and Merck has a $30B/year asset in Keytruda to protect. Stifel wrote that a proposed $28-30 takeover price for RVMD may not be enough. The author believes whoever acquires the asset will own the market and advises buying shares aggressively.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/leomeng has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
